5 matches for your search in the start-up spotlight

rss
matching the following criteria

image description
QUANTRO Therapeutics achieves breakthrough in transcriptomic drug discovery

First successful simultaneous 10-target multiplex-screening

09-Jan-2025

QUANTRO Therapeutics, a pioneer in the discovery of first-in-class transcription factor targeting cancer treatments, announced that the company has successfully completed its first ten-target multiplex-screening campaign, which yielded validated hits and functional proof of on-target activity for ...

more

image description
QUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery

28-Oct-2024

QUANTRO Therapeutics (QUANTRO), a pioneer in the discovery of first-in-class transcription factor targeting cancer treatments, announced that the company is entering into a strategic research collaboration with the group of Dr. Johannes Zuber, a world-leading expert in functional genetics and one ...

more

image description
QUANTRO Therapeutics receives important Austrian research funding to further develop its platform for the discovery of novel cancer therapies

Austrian Research Promotion Agency FFG awards funding to QUANTRO to accelerate the next development phase of the company's proprietary research platform

08-Aug-2024

QUANTRO Therapeutics GmbH, a pioneer in the development of novel transcription factor-targeted cancer therapies, announced that the company has received an 18-month research grant from the Austrian Research Promotion Agency (FFG). This will support a EUR 1.7 million research project to scale up ...

more

image description
QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments

06-Jun-2024

QUANTRO Therapeutics, aSpin-out from the research institutes IMBA and IMP in Vienna, announced that the company has reached a key milestone in its joint R&D program with Boehringer Ingelheim. In successfully applying QUANTRO’s proprietary QUANTROseq® Transcriptional Fingerprint technology, all ...

more

image description
Evotec enters partnership with Vienna start-up

Quantro exploits innovative functional-genetic and transcriptomic technologies to address “undruggable” targets

22-Jul-2020

Evotec SE announced that the Company has entered into a comprehensive partnership with the recently established QUANTRO Therapeutics GmbH, a research-based biotech company based in Vienna, Austria, that strives to discover and develop novel therapeutics interfering with disease-causing ...

more

Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE